(Q34286003)

1 August 2017

1 reference

title

Pharmacogenetics: a new diagnostic tool in the management of antidepressive drug therapy (English)

1 reference

1 August 2017

Steimer W

1

1 reference

1 August 2017

Müller B

series ordinal

2

1 reference

1 August 2017

Leucht S

series ordinal

3

1 reference

1 August 2017

Kissling W

series ordinal

4

1 reference

1 August 2017

publication date

1 June 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

308

1 reference

1 August 2017

issue

1-2

1 reference

1 August 2017

page(s)

33-41

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

1 August 2017

1 reference

Brain concentrations of tricyclic antidepressants: single-dose kinetics and relationship to plasma concentrations in chronically dosed rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Therapeutic drug monitoring of antidepressants: cost implications and relevance to clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Debrisoquine/sparteine hydroxylation genotype and phenotype: analysis of common mutations and alleles of CYP2D6 in a European population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Analysis of the CYP2D6 gene in relation to debrisoquin and desipramine hydroxylation in a Swedish population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

CYP2D6 genotype determination in the Danish population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Polymorphic debrisoquin hydroxylation in 757 Swedish subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Drug-Metabolizing Enzymes and Therapeutic Drug Monitoring in Psychiatry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Prevalence of CYP2D6 gene duplication and its repercussion on the oxidative phenotype in a white population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Pilot study of the cytochrome P450-2D6 genotype in a psychiatric state hospital.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Advances in understanding drug metabolism and its contribution to variability in patient response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Clinical implications of antidepressant pharmacokinetics and pharmacogenetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

CYP2D6 phenotype-genotype relationships in African-Americans and Caucasians in Los Angeles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Pharmacogenetic methods as a complement to therapeutic monitoring of antidepressants and neuroleptics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: screening costs and influence on clinical outcomes in psychiatry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Relationship between plasma desipramine levels, CYP2D6 phenotype and clinical response to desipramine: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Effect of adjunctive paroxetine on serum levels and side-effects of tricyclic antidepressants in depressive inpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Is therapeutic drug monitoring a case for optimizing clinical outcome and avoiding interactions of the selective serotonin reuptake inhibitors?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Clinical pharmacokinetics of selective serotonin reuptake inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Serotonin transporter gene polymorphism and antidepressant response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Organization of the human serotonin transporter gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Population studies of polymorphisms of the serotonin transporter protein gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Allelic Variation of Human Serotonin Transporter Gene Expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

A variable-number-tandem-repeat of the serotonin transporter gene and anxiety disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Efficacy of Paroxetine in Depression Is Influenced by a Functional Polymorphism Within the Promoter of the Serotonin Transporter Gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

Pharmacogenetics of antidepressants: clinical aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900423-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-8981(01)00423-5

1 reference

1 August 2017

1 reference